Clinical Trial: The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602803) titled 'The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK' on May 15.

Brief Summary: The goal of this observational study is to learn about the long-term effects of GLP1 agonists (weight loss jab, including Mounjaro) in our patients with Bardet-Biedl Syndrome (BBS) who take GLP1 agonists to treat their high body weight. The main question:

Do GLP1 agonists effectively and safely lower body weight in patients with BBS when taken long-term, compared to patients not on these medications? We look at the change (%) in weight during the observational periods.

Study Start Date: Jan. 01, 2023

Study Type: OBSERVATIONAL

Condition: ...